145 related articles for article (PubMed ID: 20738984)
1. [Progressive macular hypomelanosis successfully treated with topical clindamycin and benzoyl peroxide].
Echeverría B; Botella-Estrada R; Escutia B; Guillén C
Actas Dermosifiliogr; 2010 Jul; 101(6):565-7. PubMed ID: 20738984
[No Abstract] [Full Text] [Related]
2. The use of lymecycline and benzoyl peroxide for the treatment of progressive macular hypomelanosis: a prospective study.
Cavalcanti SM; Querino MC; Magalhães V; França ER; Magalhães M; Alencar E
An Bras Dermatol; 2011; 86(4):813-4. PubMed ID: 21987158
[TBL] [Abstract][Full Text] [Related]
3. Benzoyl peroxide/clindamycin/UVA is more effective than fluticasone/UVA in progressive macular hypomelanosis: a randomized study.
Relyveld GN; Kingswijk MM; Reitsma JB; Menke HE; Bos JD; Westerhof W
J Am Acad Dermatol; 2006 Nov; 55(5):836-43. PubMed ID: 17052490
[TBL] [Abstract][Full Text] [Related]
4. Progressive macular hypomelanosis, excellent response with narrow-band ultraviolet B phototherapy.
Montero LC; Belinchón I; Toledo F; Betlloch I
Photodermatol Photoimmunol Photomed; 2011 Jun; 27(3):162-3. PubMed ID: 21535172
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of topical combination of benzoyl peroxide 5% and clindamycin 1% for the treatment of progressive macular hypomelanosis: a randomized, doubleblind, placebo-controlled trial.
Santos JB; Almeida OL; Silva LM; Barreto ER
An Bras Dermatol; 2011; 86(1):50-4. PubMed ID: 21437522
[TBL] [Abstract][Full Text] [Related]
6. The use of a clindamycin 1%-benzoyl peroxide 5% topical gel in the treatment of pitted keratolysis: a novel therapy.
Vlahovic TC; Dunn SP; Kemp K
Adv Skin Wound Care; 2009 Dec; 22(12):564-6. PubMed ID: 19935134
[No Abstract] [Full Text] [Related]
7. New drug information. Acanya.
JAAPA; 2009 Apr; 22(4):12. PubMed ID: 19452815
[No Abstract] [Full Text] [Related]
8. A case of progressive macular hypomelanosis successfully treated with benzoyl peroxide plus narrow-band UVB.
Wu XG; Xu AE; Luo XY; Song XZ
J Dermatolog Treat; 2010 Nov; 21(6):367-8. PubMed ID: 20524876
[No Abstract] [Full Text] [Related]
9. Meta-analysis of randomized controlled trials using 5% benzoyl peroxide and clindamycin versus 2.5% benzoyl peroxide and clindamycin topical treatments in acne.
Seidler EM; Kimball AB
J Am Acad Dermatol; 2011 Oct; 65(4):e117-e119. PubMed ID: 21816505
[No Abstract] [Full Text] [Related]
10. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
Dutil M
Skin Therapy Lett; 2010; 15(10):5-7. PubMed ID: 21076800
[TBL] [Abstract][Full Text] [Related]
11. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
Langner A; Sheehan-Dare R; Layton A
J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):311-9. PubMed ID: 17309451
[TBL] [Abstract][Full Text] [Related]
12. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
Tanghetti E; Abramovits W; Solomon B; Loven K; Shalita A
J Drugs Dermatol; 2006 Mar; 5(3):256-61. PubMed ID: 16573259
[TBL] [Abstract][Full Text] [Related]
13. Taking the stress out of acne management.
Laubscher T; Regier L; Jin M; Jensen B
Can Fam Physician; 2009 Mar; 55(3):266-9. PubMed ID: 19282536
[No Abstract] [Full Text] [Related]
14. Fixed-combination monotherapy with clindamycin 1%- benzoyl peroxide 5% gel: focus on acne patient benefits and clinical use. Introduction.
Eichenfield L
Cutis; 2009 Nov; 84(5 Suppl):3-4. PubMed ID: 19999186
[No Abstract] [Full Text] [Related]
15. Cutibacterium acnes persists despite topical clindamycin and benzoyl peroxide.
Heckmann N; Heidari KS; Jalali O; Weber AE; She R; Omid R; Vangsness CT; Rick Hatch GF
J Shoulder Elbow Surg; 2019 Dec; 28(12):2279-2283. PubMed ID: 31471244
[TBL] [Abstract][Full Text] [Related]
16. Combination topical therapy in the treatment of acne.
Del Rosso JQ
Cutis; 2006 Aug; 78(2 Suppl 1):5-12. PubMed ID: 17966494
[TBL] [Abstract][Full Text] [Related]
17. Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
Bikowski J; Callender VD; Del Rosso JQ; Draelos ZD; Tanghetti E
Cutis; 2006 Aug; 78(2 Suppl 1):13-20. PubMed ID: 17966495
[TBL] [Abstract][Full Text] [Related]
18. The efficacy and safety of a combination benzoyl peroxide/clindamycin topical gel compared with benzoyl peroxide alone and a benzoyl peroxide/erythromycin combination product.
Leyden JJ; Hickman JG; Jarratt MT; Stewart DM; Levy SF
J Cutan Med Surg; 2001; 5(1):37-42. PubMed ID: 11281433
[TBL] [Abstract][Full Text] [Related]
19. The pulsed-dye laser as an adjuvant treatment modality in acne vulgaris: a randomized controlled single-blinded trial.
Karsai S; Schmitt L; Raulin C
Br J Dermatol; 2010 Aug; 163(2):395-401. PubMed ID: 20394631
[TBL] [Abstract][Full Text] [Related]
20. Fixed-combination clindamycin 1%-benzoyl peroxide 5% hydrating gel: a flexible component of acne management.
Tanghetti E
Cutis; 2009 Nov; 84(5 Suppl):18-24. PubMed ID: 19999189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
